Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00951444 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study was not activated.

Conditions

Lung Cancer

Interventions

BIOLOGICAL: dalotuzumab
DRUG: carboplatin
DRUG: gemcitabine hydrochloride

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]